Order results by:
| Issue | Title | |
| Vol 15, No 6 (2019) | Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction | Abstract similar documents |
| Ya. G. Bozhko, M. V. Arkhipov, N. A. Belokonova | ||
| "... between main and control groups in magnesium in whole blood (0.48 [0.44-0.51] mmol/l vs 0.55 [0.5-0 ..." | ||
| Vol 7, No 4 (2011) | FOCUS ON MAGNESIUM BASED DRUGS | Abstract similar documents |
| I. I. Esenova | ||
| "... Magnesium deficiency in the organism is one of the most common human deficiency states ..." | ||
| Vol 8, No 4 (2012) | MAGNESIUM IN CLINICAL PRACTICE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... Magnesium is a macronutrient that is needed for normal body functions. Magnesium deficiency ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... At present experimental and clinical data confirming efficacy of magnesium-containing drugs ..." | ||
| Vol 11, No 2 (2015) | MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS | Abstract similar documents |
| L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov | ||
| "... Aim. To study the effect of magnesium orotate, magnesium/pyridoxine combination and magnesium ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..." | ||
| Vol 4, No 5 (2008) | MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..." | ||
| Vol 6, No 5 (2010) | MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION | Abstract similar documents |
| A. G. Avtandilov, K. M. Dzeranova, A. A. Pukhaeva, E. D. Manizer | ||
| "... magnesium one is the mostly important in CTD manifestations. Pathogenetic pharmacotherapy should ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... Data on the effect of magnesium on the homeostasis of the body and on the cardiovascular system ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... The article is devoted to the influence of magnesium on the homeostasis of the body ..." | ||
| Vol 6, No 5 (2010) | POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN | Abstract similar documents |
| A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta | ||
| "... Role of magnesium and potassium deficiency in the development of cardiovascular diseases ..." | ||
| Vol 3, No 3 (2007) | COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS | Abstract similar documents |
| E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova | ||
| "... Aim. To compare effects of monotherapy with magnesium and combined therapy with magnesium and β ..." | ||
| Vol 13, No 1 (2017) | CHANGE IN CONTENT OF GLYCOPROTEINS ON THE SURFACE OF ENDOTHELIAL CELL CULTURE EA.HY 926 AND INTIMA OF INTERNAL CAROTID ARTERIES UNDER THE INFLUENCE OF MAGNESIUM OROTATE | Abstract similar documents |
| L. V. Didenko, E. A. Ulubieva, T. G. Borovaya, A. G. Avtandilov, N. V. Shevlyagina, V. G. Zhukhovitsky, O. M. Grinkevich, M. V. Mezentseva | ||
| "... the influence of magnesium orotate. Material and methods. Endotheliocytes of cell culture EA.hy 926 were ..." | ||
| Vol 21, No 2 (2025) | Replenishment of intracellular magnesium deficiency in cardiac arrhythmias: focus on the physicochemical properties of complex compounds | Abstract similar documents |
| Ya. G. Bozhko, N. A. Belokonova, O. M. Medvedeva, K. A. Butova, M. V. Arkhipov | ||
| "... Aim. To identify the most promising drug composition for replenishing intracellular magnesium ..." | ||
| Vol 6, No 4 (2010) | MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev | ||
| "... Aim. To study relationship of the clinical state and cardiac functional parameters with magnesium ..." | ||
| Vol 8, No 6 (2012) | THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY | Abstract similar documents |
| K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina | ||
| "... ) while taking magnesium orotate. Material and methods. Patients with MVP and phenotypic characteristics ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY | Abstract similar documents |
| A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko | ||
| "... contractility in patients with mitral valve prolapse before and after magnesium orotate course. Material ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of different ASA formulations have been continuing. Magnesium hydroxide included in combined medicine ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... <0.05). In patients with MS, a significant negative correlation of EEC with total cholesterol (r=-0.51 ..." | ||
| Vol 18, No 5 (2022) | Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, D. F. Nizamova | ||
| "... are established in patients with class III-IV CHF between IGF-1 level and NT-pro BNP levels (r=-0,51; р=0 ..." | ||
| Vol 16, No 1 (2020) | Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya | ||
| "... stenosis of 70% or more for each patient using formula Р, where L=0.89-1.09×gender+ 0.51×triglycerides–0 ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... of bleeding was significantly lower with NOACs (RR=0.70; 95% CI 0.51-0.95; p=0.02). All-cause mortality rate ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... of bleeding was significantly lower with NOACs (RR=0.70; 95% CI 0.51-0.95; p=0.02). All-cause mortality rate ..." | ||
| Vol 9, No 3 (2013) | IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION | Abstract similar documents |
| P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva | ||
| "... .3%; р=0.42); repeated PCI (yes — 23.7%; no — 26.3%; р=0.98); death (yes — 28.6%; no — 25%; р=0.51 ..." | ||
| Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
| "... ,18-3,31), and probability of aspirin prescription was lower (OR 0.82; 95% CI 0,51-1,32; p>0 ..." | ||
| Vol 15, No 5 (2019) | Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure | Abstract similar documents |
| E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava | ||
| "... [20;29]%; p<0.001). Only in men PWV weakly correlated with AI 75 (r=0.44; p=0.02 versus r=-0.11; p=0.51 ..." | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... ,01; r=-0,2; p=0,05), у пациентов контрольной группы – НF и LF (r=-0,54; p=0,002; r=-0,51; p=0 ..." | ||
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... count (β=1.47, 95% CI: 0.51-2.42; p=0.0027); platelets count (β=0.042, 95% CI: 0.019-0.064; p=0 ..." | ||
| Vol 10, No 2 (2014) | RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL | Abstract similar documents |
| J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson | ||
| "... увеличения частоты смертельных кровотечений (0,2% против 0,1%, р=0,51). Заключение. У пациентов, недавно ..." | ||
| 1 - 30 of 30 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
